分子診断検査の世界市場:用途、技術(PCR、マイクロアレイ、DNAシークエンシング)、製品(試薬、装置、ソフトウェア)...市場調査レポートについてご紹介

【英文タイトル】Molecular Diagnostics Market by Application (Infectious Disease (HIV, HPV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Microarray, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Software) - Forecast to 2020

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Introduction (Page No. – 25)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Markets Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders

2 Research Methodology (Page No. – 29)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.2.1 Key Data From Secondary Sources
2.2.2 Key Data From Primary Sources
2.2.2.1 Key Industry Insights
2.2.3 Assumptions

3 Executive Summary (Page No. – 37)

4 Premium Insights (Page No. – 43)
4.1 Molecular Diagnostics Market
4.2 Market,Infectious Diseases
4.3 Market, By Technology and Application
4.4 Market, By End User
4.5 Market, By Products and Services

5 Market Overview (Page No. – 47)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Prevalence Rate of Infectious Diseases and Various Types of Cancer
5.2.1.2 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
5.2.1.3 Development of Biomarker Identification and Advancements in Molecular Techniques
5.2.1.4 Growth in Proteomics and Genomics Research
5.2.1.5 Reforms in the Reimbursement System in the U.S.
5.2.2 Restraints
5.2.2.1 Molecular Diagnostic Tools With New and Complex Platforms Demand Skilled Labor and Mandatory Training
5.2.2.2 Complex Regulatory Framework to Delay Approvals of New Molecular Diagnostic Tests
5.2.3 Opportunities
5.2.3.1 Advances in Genomics
5.2.3.2 Significant Growth Prospects in Developing Countries
5.2.4 Challenge
5.2.4.1 Dearth of Trained Professionals Limiting the Appropriate Use of New Molecular Diagnostic Technologies

6 Molecular Diagnostics Market, By Application (Page No. – 56)
6.1 Introduction
6.2 Infectious Diseases
6.2.1 Hepatitis B
6.2.2 Hepatitis C
6.2.3 Human Immunodeficiency Virus (HIV)
6.2.4 Tuberculosis (TB)
6.2.5 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
6.2.6 Human Papillomavirus (HPV)
6.2.7 Methicillin-Resistant Staphylococcus Aureus (MRSA)
6.2.8 Others
6.3 Oncology
6.3.1 Prostate Cancer
6.3.2 Breast Cancer
6.4 Colorectal Cancer
6.5 Others
6.6 Genetic Tests
6.7 Blood Screening
6.8 Microbiology
6.9 Others

7 Molecular Diagnostics Market, By Technology (Page No. – 87)
7.1 Introduction
7.2 Polymerase Chain Reaction (PCR)
7.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
7.4 Microarrays
7.5 Hybridization (In-Situ Hybridization & Fish)
7.6 DNA Sequencing and Next-Generation Sequencing
7.7 Other Technologies

8 Molecular Diagnostics Market, By Products and Services (Page No. – 110)
8.1 Introduction
8.2 Reagents
8.3 Instruments
8.4 Software & Services

9 Molecular Diagnostics Market, By End User (Page No. – 124)
9.1 Introduction
9.2 Hospital/Academic Laboratories
9.3 Reference Laboratories
9.4 Other End Users

10 Molecular Diagnostic Market, By Region (Page No. – 136)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 U.K.
10.3.2 Germany
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe (RoE)
10.4 Asia
10.4.1 Japan
10.4.2 India
10.4.3 China
10.4.4 Rest of Asia (RoA)
10.5 Rest of the World (RoW)
10.5.1 Latin America
10.5.1.1 Mexico
10.5.1.2 Brazil
10.5.1.3 Rest of Latin America (RoLA)
10.5.2 Pacific Countries
10.5.3 Middle East & Africa

11 Competitive Landscape (Page No. – 192)
11.1 Overview
11.2 Market Share Analysis
11.3 Molecular Diagnostics Market Competitor Share Analysis, By Application
11.3.1 Market Share Analysis for Infectious Disease Diagnostics Applications
11.3.2 Market Share Analysis for Blood Screening Applications
11.3.3 Market Share Analysis for Microbiology Applications
11.3.4 Market Share Analysis for Oncology Applications
11.3.5 Market Share Analysis for Genetic Testing Applications
11.4 Molecular Diagnostics Market Share Analysis, By Technology
11.4.1 Polymerase Chain Reaction (PCR)
11.4.2 DNA Sequencing and Ngs
11.4.3 Microarray
11.4.4 Hybridization (In Situ and Fluorescence)
11.4.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
11.5 Product Approvals
11.6 Agreements, Collaborations, and Partnerships
11.7 New Product Launches
11.8 Acquisitions
11.9 Other Developments

12 Company Profiles (Page No. – 208)
12.1 Introduction
12.2 Abbott Laboratories
12.2.1 Business Overview
12.2.2 Abbott Laboratories: Company Snapshot
12.2.3 Products Offered
12.2.4 Recent Developments
12.2.5 MnM View
12.3 Qiagen N.V.
12.3.1 Business Overview
12.3.2 Qiagen N.V.: Company Snapshot
12.3.3 Products & Services Offered
12.3.4 Recent Developments
12.3.5 MnM View
12.4 Roche Diagnostics
12.4.1 Business Overview
12.4.2 Roche Diagnostics: Company Snapshot
12.4.3 Products Offered
12.4.4 Recent Developments
12.4.5 MnM View
12.5 Hologic, Inc.
12.5.1 Business Overview
12.5.2 Hologic, Inc.: Company Snapshot
12.5.3 Products Offered
12.5.4 Recent Developments
12.5.5 MnM View
12.6 Grifols
12.6.1 Business Overview
12.6.2 Grifols: Company Snapshot
12.6.3 Products Offered
12.6.4 Recent Developments
12.6.5 MnM View
12.7 Siemens Healthcare
12.7.1 Business Overview
12.7.2 Siemens Healthcare: Company Snapshot
12.7.3 Products Offered
12.7.4 Recent Developments
12.8 Becton, Dickinson and Company
12.8.1 Business Overview
12.8.2 Becton, Dickinson and Company: Company Snapshot
12.8.3 Products & Services Offered
12.8.4 Recent Developments
12.9 Beckman Coulter Inc. (Wholly Owned Subsidiary of Danaher Corporation)
12.9.1 Business Overview
12.9.2 Danaher Corporation: Company Snapshot
12.9.3 Products & Services Offered
12.9.4 Recent Developments
12.10 Biomérieux SA
12.10.1 Business Overview
12.10.2 Biomérieux: Company Snapshot
12.10.3 Products Offered
12.10.4 Recent Developments
12.11 Cepheid Inc.
12.11.1 Business Overview
12.11.2 Cepheid Inc.: Company Snapshot
12.11.3 Products Offered
12.11.4 Recent Developments

13 Appendix (Page No. – 263)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Other Developments
13.3.1 Abbott Laboratories
13.3.2 Qiagen N.V.
13.3.3 Roche Diagnostics
13.3.4 Hologic Inc.
13.3.5 Hologic Inc.
13.3.6 Siemens Healthcare
13.3.7 Becton, Dickinson and Company
13.3.8 Becton, Dickinson and Company
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports


【レポート販売概要】

■ タイトル:分子診断検査の世界市場:用途、技術(PCR、マイクロアレイ、DNAシークエンシング)、製品(試薬、装置、ソフトウェア)
■ 英文:Molecular Diagnostics Market by Application (Infectious Disease (HIV, HPV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Microarray, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Software) - Forecast to 2020
■ 発行日:2015年11月16日
■ 調査会社:MarketsandMarkets
■ 商品コード:MAM-MD-2521
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。